010600 — WellBiotec Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro Cap

Annual balance sheet for WellBiotec Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23,020	8,301	7,924	13,626	15,284
Net Total Accounts Receivable
Net Total Receivables	20,424	14,214	26,928	25,559	12,084
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	72,351	29,929	124,386	46,932	38,747
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13,329	2,405	1,872	1,756	4,046
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	119,824	70,921	139,383	59,285	60,241
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32,845	41,740	100,661	22,640	20,570
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	43,521	51,935	102,840	24,517	22,235
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	76,303	18,986	36,544	34,769	38,006
Total Liabilities & Shareholders' Equity	119,824	70,921	139,383	59,285	60,241
Total Common Shares Outstanding